Kazuyuki Nakagome, MD, PhD, Yury A

Slides:



Advertisements
Similar presentations
Early exposure to cow's milk protein is protective against IgE-mediated cow's milk protein allergy Yitzhak Katz, MD, Nelly Rajuan, MSc, Michael R. Goldberg,
Advertisements

Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.
Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 
An IgE-associated polymorphism in STAT6 alters NF-κB binding, STAT6 promoter activity, and mRNA expression  Michaela Schedel, PhD, Remo Frei, PhD, Christian.
Advances in food allergy in 2015
Epigenetic regulation of established human type 1 versus type 2 cytokine responses  Ruey-Chyi Su, PhD, Allan B. Becker, MD, Anita L. Kozyrskyj, PhD, Kent.
Regulation of GM-CSF expression by the transcription factor c-Maf
Epigenetic mechanisms silence a disintegrin and metalloprotease 33 expression in bronchial epithelial cells  Youwen Yang, PhD, Hans Michael Haitchi, MD,
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
The role of viruses in acute exacerbations of asthma
Induction of B7-H1 and B7-DC expression on airway epithelial cells by the Toll-like receptor 3 agonist double-stranded RNA and human rhinovirus infection:
Robert F. Lemanske, MD, Daniel J. Jackson, MD, Ronald E
Nitric oxide inhibits human rhinovirus-induced transcriptional activation of CXCL10 in airway epithelial cells  Rommy Koetzler, MD, MSc, Raza S. Zaheer,
Nazanin Farhadi, MSc, Laura Lambert, BA, Chiara Triulzi, PhD, Peter J
Neonatal rhinovirus induces mucous metaplasia and airways hyperresponsiveness through IL-25 and type 2 innate lymphoid cells  Jun Young Hong, MS, J. Kelley.
Is 9 more than 2 also in allergic airway inflammation?
Frederick J. Rubner, MD, Daniel J. Jackson, MD, Michael D
Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 
Specificity protein 1 is pivotal in the skin’s antiviral response
Volume 7, Issue 4, Pages (April 2003)
Recurrent anaphylaxis linked to pantoprazole
Association of rhinovirus species with common cold and asthma symptoms and bacterial pathogens  Hiba Bashir, MD, Kristine Grindle, BS, Rose Vrtis, BS,
Human IL-31 is induced by IL-4 and promotes TH2-driven inflammation
Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J
Detection of pathogenic bacteria during rhinovirus infection is associated with increased respiratory symptoms and asthma exacerbations  Kirsten M. Kloepfer,
Adhesion of Streptococcus pneumoniae to human airway epithelial cells exposed to urban particulate matter  Naseem Mushtaq, PhD, Majid Ezzati, PhD, Lucinda.
Corticosteroid insensitivity of chemokine expression in airway smooth muscle of patients with severe asthma  Po-Jui Chang, MD, Pankaj K. Bhavsar, PhD,
In vitro susceptibility to rhinovirus infection is greater for bronchial than for nasal airway epithelial cells in human subjects  Nilceia Lopez-Souza,
Chemokine release from human rhinovirus–infected airway epithelial cells promotes fibroblast migration  Christopher Shelfoon, BSc, Sami Shariff, BSc,
Physician needs in health informatics: Just ask the docs
Cytokine response after severe respiratory syncytial virus bronchiolitis in early life  Mario Castro, MD, MPH, Toni Schweiger, RN, Huiquing Yin-DeClue,
IL-33 in clinical practice: Size matters?
Itai M. Pessach, MD, PhD, Luigi D. Notarangelo, MD 
Peter M. Wolfgram, MD, David B. Allen, MD 
Etiology of asthma exacerbations
The future of allergy/immunology: Promising young investigators
Daniel J. Jackson, MD, James E. Gern, MD, Robert F. Lemanske, MD 
William J. Calhoun, MD, Tmirah Haselkorn, PhD, Dave P
Interferon response and respiratory virus control are preserved in bronchial epithelial cells in asthma  Dhara A. Patel, PhD, Yingjian You, BA, Guangming.
Fibronectin is a TH1-specific molecule in human subjects
Xingnan Li, PhD, Timothy D. Howard, PhD, Siqun L
Jewlya Lynn, PhD, Sophie Oppenheimer, MS, MPH, Lorena Zimmer, MA 
Antiviral activity of human β-defensin 3 against vaccinia virus
Exogenous IFN-β has antiviral and anti-inflammatory properties in primary bronchial epithelial cells from asthmatic subjects exposed to rhinovirus  Julie.
Debra J. Palmer, PhD, Thomas R. Sullivan, BMa&CompSc(Hons), Michael S
Sabine Leisten, MSc, Michiko K
Airway epithelial cells activate TH2 cytokine production in mast cells through IL-1 and thymic stromal lymphopoietin  Deepti R. Nagarkar, PhD, Julie A.
Nitric oxide inhibits IFN regulatory factor 1 and nuclear factor-κB pathways in rhinovirus- infected epithelial cells  Rommy Koetzler, MD, MSc, Raza S.
Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management  Scott H. Sicherer, MD, Hugh A. Sampson, MD  Journal.
Biosimilars and drug development in allergic and immunologic diseases
Kirsten M. Kloepfer, MD, MS, Vishal K
Liam O’Mahony, PhD, Mübeccel Akdis, MD, PhD, Cezmi A. Akdis, MD 
H. William Kelly, PharmD  Journal of Allergy and Clinical Immunology 
Autophagy: Nobel Prize 2016 and allergy and asthma research
The role of rhinovirus in asthma exacerbations
Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment
Chemokines and their receptors in allergic disease
Bidirectional interactions between viral respiratory illnesses and cytokine responses in the first year of life  James E. Gern, MD, G. Daniel Brooks,
Weekly monitoring of children with asthma for infections and illness during common cold seasons  Jaime P. Olenec, MD, Woo Kyung Kim, MD, Wai-Ming Lee,
Halie M. Anderson, MD, Robert F. Lemanske, MD, Michael D
Propagation of respiratory viruses in human airway epithelia reveals persistent virus- specific signatures  Manel Essaidi-Laziosi, PhD, Francisco Brito,
Innate immune responses to infection
Biju Thomas, MD, Robert Anthony Hirst, PhD, Mina H
Cytokine modulation of atopic dermatitis filaggrin skin expression
Asthma: The past, future, environment, and costs
Tuomas Jartti, MD, James E. Gern, MD 
Environmental factors and eosinophilic esophagitis
Natural history of cow’s milk allergy
Primary prevention of asthma and allergy
Keiji Miyazawa, MSc, Akio Mori, MD, PhD, Hirokazu Okudaira, MD, PhD 
Presentation transcript:

Effects of rhinovirus species on viral replication and cytokine production  Kazuyuki Nakagome, MD, PhD, Yury A. Bochkov, PhD, Shamaila Ashraf, PhD, Rebecca A. Brockman-Schneider, MS, Michael D. Evans, MS, Thomas R. Pasic, MD, James E. Gern, MD  Journal of Allergy and Clinical Immunology  Volume 134, Issue 2, Pages 332-341.e10 (August 2014) DOI: 10.1016/j.jaci.2014.01.029 Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 Effect of RVs on viral replication in differentiated HSECs. The amount of RV RNA in adherent cells was measured just PI (A) or at 24 hours PI (B) (n = 5). C and D, Viral types were combined by species. The amounts of RV RNA (C) and net increase in RV RNA (D) are shown (n = 15). E, Growth kinetics of infection of RV-A, RV-B, and RV-C (n = 15). **P < .01 and ***P < .001 (vs RV-B). Journal of Allergy and Clinical Immunology 2014 134, 332-341.e10DOI: (10.1016/j.jaci.2014.01.029) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 Effect of inoculation dose of RVs on viral replication. The amount of RV RNA was measured just PI (A) or at 24 hours PI (B) (n = 5). C, The relationship between the amount of RV RNA just PI (viral binding) and that at 24 hours PI is shown. D, Z-score of amounts of RV RNA at 24 hours PI after adjusting for viral binding. *P < .05, **P < .01, and ***P < .001 (vs RV-B52). Journal of Allergy and Clinical Immunology 2014 134, 332-341.e10DOI: (10.1016/j.jaci.2014.01.029) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 3 Effect of RVs on cellular cytotoxicity or apoptosis. A, Time course of cellular cytotoxicity (n = 15). Cellular cytotoxicity at 72 hours PI caused by individual RV types (B) (n = 5) or from groups that were combined by species (C) (n = 15). D, Cells were collected at 24 hours PI and caspase 3/7 activity was assessed (n = 5). Staurosporine (Stau; 50 μM) was used as a positive control. **P < .01 (vs RV-B), ###P < .001 (vs mock-infected cells). Journal of Allergy and Clinical Immunology 2014 134, 332-341.e10DOI: (10.1016/j.jaci.2014.01.029) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 4 Effect of RVs on viral replication and cellular cytotoxicity in WisL cells transfected with RV RNA. We transfected WisL cells with RNA of RV-A16, RV-B52, or RV-C15 (0.25 [A] or 2.5 μg [B]). Cells were collected and RV-RNA was measured (n = 5). **P < .01 and ***P < .001 (vs RV-B52). C, Cytopathic effects observed 16 hours after transfection. Scale bars, 100 μm. Journal of Allergy and Clinical Immunology 2014 134, 332-341.e10DOI: (10.1016/j.jaci.2014.01.029) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 5 Effect of RVs on cytokine production. CXCL10 (A-C), CXCL11 (D-F), CCL5 (G-I), and IFN-λ1 (J-L) concentrations were measured in basal medium after RV inoculation. Time course of cytokine production (A, D, G, J) (n = 15). Cytokine production at 48 hours PI from individual RV types (B, E, H, K) (n = 5) or from groups that were combined by species (C, F, I, L) (n = 15). *P < .05, **P < .01, and ***P < .001 (vs RV-B). Journal of Allergy and Clinical Immunology 2014 134, 332-341.e10DOI: (10.1016/j.jaci.2014.01.029) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 6 Relationship between cytokine production and virus load. A, The relationship between CXCL10 concentrations and virus load at 48 hours PI. B, Z-score of CXCL10 concentrations after adjusting for virus load at 48 hours PI. C, The relationship between IFN-λ1 concentrations and virus load at 48 hours PI. D, Z-score of IFN-λ1 concentrations after adjusting for virus load at 48 hours PI. *P < .05 and ***P < .001 (vs RV-B). Journal of Allergy and Clinical Immunology 2014 134, 332-341.e10DOI: (10.1016/j.jaci.2014.01.029) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E1 Construction of the full-length cDNA copy of RV-B52. The genome of the B52 consists of a single open-reading frame flanked by the 5′ and 3′ untranslated regions and encodes 1 large polyprotein that is cleaved to provide mature viral proteins (1A-1D, 2A-2C, 3A-3D). Five overlapping cDNA fragments were synthesized by RT-PCR from viral genomic RNA by using primers (Table E1). To clone the full-length cDNA of B52, pMJ3 was digested with SalI and BamHI and separately ligated to insert 1 with an upstream T7 promoter and ribozyme to make “pB52 ins1,” and then ligated to insert 3 to make “pB52 ins3.” Insert 2 was cloned into “pB52 ins1” by using BamHI and SacI restriction sites to make “pB52 ins1&2.” Insert 4 was next cloned into “pB52 ins3” by using HpaI and XmaI restriction sites to make “pB52 ins3&4” and then insert 5 was cloned into “pB52 ins3&4” by using XbaI and SacI to make “pB52 ins3-5.” Finally, the cDNA fragment that contained inserts 1 and 2 was excised from “pB52 ins 1&2” by using SalI, and this fragment was then ligated into “pB52 ins3-5” to make “pB52.” The final recombinant plasmid pB52 contained a full-length cDNA copy of the viral RNA downstream of a T7 promoter and ribozyme. Journal of Allergy and Clinical Immunology 2014 134, 332-341.e10DOI: (10.1016/j.jaci.2014.01.029) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E2 Construction of the full-length cDNA copy of RV-B72. The genome of the B72 consists of a single open-reading frame flanked by the 5′ and 3′ untranslated regions, and encodes 1 large polyprotein that is cleaved to provide mature viral proteins (1A-1D, 2A-2C, 3A-3D). Four overlapping cDNA fragments were synthesized by RT-PCR from viral genomic RNA by using primers (Table E1). To clone the full-length cDNA of B72, pB52 was digested with XmaI and SacI and then ligated to insert 1 with an upstream T7 promoter and ribozyme to make “pB72 ins1.” Insert 2 was cloned into “pB72 ins1” by using NheI and SacI restriction sites to make “pB72 ins1&2.” Insert 3 was next cloned into “pB72 ins1&2” by using Blp1 and SacI restriction sites to make “pB72 ins1-3.” Finally, insert 4 was cloned into “pB72 ins1-3” by using HpaI and SacI to make “pB72.” The final recombinant plasmid pB72 contained a full-length cDNA copy of the viral RNA downstream of a T7 promoter and ribozyme. Journal of Allergy and Clinical Immunology 2014 134, 332-341.e10DOI: (10.1016/j.jaci.2014.01.029) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E3 Construction of the full-length cDNA copy of RV-A36. The genome of the A36 consists of a single open-reading frame flanked by the 5′ and 3′ untranslated regions, and encodes 1 large polyprotein that is cleaved to provide mature viral proteins (1A-1D, 2A-2C, 3A-3D). Five overlapping cDNA fragments were synthesized by RT-PCR from viral genomic RNA by using primers (Table E1). To clone the full-length cDNA of A36, pB52 was digested with XmaI and SacI, and then ligated to insert 1 with an upstream T7 promoter and ribozyme to make “pA36 ins1.” Insert 2 was cloned into “pA36 ins1” by using HpaI and SacI restriction sites to make “pA36 ins1&2.” Insert 3 was next cloned into “pA36 ins1&2” by using Nde1 and SacI restriction sites to make “pA36 ins1-3.” Insert 4 was then cloned into “pA36 ins1-3” by using BssHII and SacI to make “pA36 ins1-4.” Finally, insert 5 was cloned into “pA36 ins1-4” by using SpeI and SacI to make “pA36.” The final recombinant plasmid pA36 contained a full-length cDNA copy of the viral RNA downstream of a T7 promoter and ribozyme. Journal of Allergy and Clinical Immunology 2014 134, 332-341.e10DOI: (10.1016/j.jaci.2014.01.029) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E4 Construction of the full-length cDNA copy of RV-C41. The genome of the C41 consists of a single open-reading frame flanked by the 5′ and 3′ untranslated regions, and encodes 1 large polyprotein that is cleaved to provide mature viral proteins (1A-1D, 2A-2C, 3A-3D). Five overlapping cDNA fragments were synthesized by RT-PCR from viral genomic RNA by using primers (Table E1). To clone the full-length cDNA of C41, pA36 was digested with XmaI and SacI, and ligated to insert 1 with an upstream T7 promoter and ribozyme to make “pC41 ins1.” Insert 2 was cloned into “pC41 ins1” by using NdeI and SacI restriction sites to make “pC41 ins1&2,” and then insert 3 was cloned into “pC41 ins1&2” by using SpeI and SacI to make “pC41 ins1-3”; pB72 was digested with NheI and SacI, and ligated to insert 4 to make “pC41 ins4.” Insert 5 was next cloned into “pC41 ins4” by using BlpI and SacI to make “pC41 ins4&5.” Finally, the cDNA fragment that contained inserts 4 and 5 was excised from “pC41 ins 4&5” by using NheI and SacI, and this fragment was then ligated into “pC41 ins1-3” to make “pC41.” The final recombinant plasmid pC41 contained a full-length cDNA copy of the viral RNA downstream of a T7 promoter and ribozyme. Journal of Allergy and Clinical Immunology 2014 134, 332-341.e10DOI: (10.1016/j.jaci.2014.01.029) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E5 Amounts of RV RNA in adherent cells and in the growth media. We infected differentiated HSECs with viruses (RV-A16, B52, or C15; 108 RNA copies/sample) and then quantitated RV RNA in adherent cells or that released into the media by qRT-PCR at 24 hours PI. The amounts of RV RNA in adherent cells and those released into the media in log scale are shown. *P < .05 and **P < .01 (vs RV-B52). ###P < .001 (RV RNA in cells vs the media). Journal of Allergy and Clinical Immunology 2014 134, 332-341.e10DOI: (10.1016/j.jaci.2014.01.029) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E6 The effect of RVs on cytokine production at 72 hours PI in differentiated HSECs. CXCL10 (A, B), CXCL11 (C, D), CCL5 (E, F), and IFN-λ1 (G, H) concentrations were measured in basal medium. Cytokine production at 72 hours PI from individual virus (A, C, E, G) (n = 5) or from groups that were combined (B, D, F, H) (n = 15). **P < .01 and ***P < .001 (vs RV-B). Journal of Allergy and Clinical Immunology 2014 134, 332-341.e10DOI: (10.1016/j.jaci.2014.01.029) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig E7 The effect of RVs on viral replication in differentiated PBECs. The amount of RV RNA in adherent cells in log scale was measured just after infection or at 24 hours PI (n = 5). *P < .05 and **P < .01 (vs RV-B52). Journal of Allergy and Clinical Immunology 2014 134, 332-341.e10DOI: (10.1016/j.jaci.2014.01.029) Copyright © 2014 American Academy of Allergy, Asthma & Immunology Terms and Conditions